The company's radiation safety team allegedly neglected to ensure that a specific safeguard was working properly at a silicon ...

Despite AI-driven growth in the semiconductor industry, South Korea is facing a critical shortage of skilled workers. A ...

Semiconductor manufacturers will spend a record $400 billion on computer chip-making equipment in 2025-2027, global industry ...

Nvidia and AMD, two prominent US clients of TSMC, have recently hinted at expanding their chip manufacturing partnerships.

Chinese tech giant Huawei, once crippled by U.S. trade sanctions, has now taken the lead over Samsung Electronics with the ...

South Korea's Samsung Display Co plans to invest $1.8 billion for a factory in northern Vietnam to produce OLED displays for ...

Returns might improve, but the power of chaebols—including Samsung and Hyundai—will limit the gains.

South Korean companies are flocking to the US to take advantage of Biden's incentives to manufacture chips, batteries, and ...

The gauge will be launched on Sept 30, and index futures and ETF products will be added in November, according to Korea ...

Samsung has delayed One UI 6.1.1 updates for the Galaxy S24, S23, and S22 series, causing frustration among owners. One UI ...

Galaxy AI debuted on the Galaxy S24 series with One UI 6.1, and the Z Fold 4 received this update shortly after. One UI 6.1.1 expands Galaxy AI, adding features like sketch to image, new portrait ...

INCHEON, South Korea和CAMBRIDGE, Mass. - Samsung Bioepis Co., Ltd.和Biogen Inc. (NASDAQ:BIIB)宣布取得重要的监管里程碑,欧洲药品管理局人用药品委员会 (CHMP)支持OPUVIZ™的上市授权。这种生物仿制药参考了Eylea (aflibercept),被称为SB15,推荐用于治疗多种视网膜疾病。